Literature DB >> 15075661

Vascular smooth muscle cell endovascular therapy stabilizes already developed aneurysms in a model of aortic injury elicited by inflammation and proteolysis.

Eric Allaire1, Béatrice Muscatelli-Groux, Anne-Marie Guinault, Carine Pages, Audrey Goussard, Chantal Mandet, Patrick Bruneval, Didier Méllière, Jean-Pierre Becquemin.   

Abstract

OBJECTIVE: To investigate the efficiency of endovascular smooth muscle cell (VSMC) seeding in promoting healing and stability in already-developed aneurysms obtained by matrix metalloproteases (MMPs)-driven injury. SUMMARY BACKGROUND DATA: VSMCs are instrumental in arterial healing after injury and are in decreased number in arterial aneurysms. This cellular deficiency may account for poor healing capabilities and ongoing expansion of aneurysms.
METHODS: Aneurysmal aortic xenografts in rats displaying extracellular matrix injury by inflammation and proteolysis were seeded endoluminally with syngeneic VSMCs, with controls receiving culture medium only. Diameter, structure, and the destruction/reconstruction balance were assessed.
RESULTS: Eight weeks after endovascular infusion, aneurysmal diameter had increased further, from 3.0 +/- 0.3 mm to 10.9 +/- 6.5 mm (P = 0.009), and medial elastin content had decreased from 36.5 +/- 8.5 to 5.2 +/- 5.5 surface-percent (S%; P = 0.009) in controls, whereas these parameters remained stable in the seeded group (3.0 +/- 0.3 to 2.7 +/- 0.2 mm, P = 0.08; 36.5 +/- 8.4 to 31.6 +/- 9.7 S%, P = 0.22). VSMC seeding was followed by a decrease in mononuclear infiltration. MMP-1, -3, -7, -9, and -12 mRNA contents were sharply decreased in the diseased wall in response to seeding. Tissue inhibitor of metalloproteinase-1, -2, and -3 mRNAs in the intima were increased in a 2 to 10 magnitude in comparison with controls. Gelatin zymography showed the disappearance of MMP-9 activity and reverse zymography a strong increase in tissue inhibitor of metalloproteinase-3 activity in the seeded group. VSMC-seeded aneurysms were rich in collagen and lined with an endothelium instead of a thrombus in controls.
CONCLUSIONS: VSMCs endovascular seeding restores the healing capabilities of proteolytically injured extracellular matrix in aneurysmal aortas, and stops expansion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15075661      PMCID: PMC1356242          DOI: 10.1097/01.sla.0000114131.79899.82

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  31 in total

1.  The immunogenicity of the extracellular matrix in arterial xenografts.

Authors:  E Allaire; P Bruneval; C Mandet; J P Becquemin; J B Michel
Journal:  Surgery       Date:  1997-07       Impact factor: 3.982

2.  Shear stress regulates smooth muscle proliferation and neointimal thickening in porous polytetrafluoroethylene grafts.

Authors:  L W Kraiss; T R Kirkman; T R Kohler; B Zierler; A W Clowes
Journal:  Arterioscler Thromb       Date:  1991 Nov-Dec

3.  Mechanisms of arterial graft failure. 1. Role of cellular proliferation in early healing of PTFE prostheses.

Authors:  A W Clowes; A M Gown; S R Hanson; M A Reidy
Journal:  Am J Pathol       Date:  1985-01       Impact factor: 4.307

4.  Increased blood flow induces regression of intimal hyperplasia.

Authors:  E J Mattsson; T R Kohler; S M Vergel; A W Clowes
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-10       Impact factor: 8.311

5.  Elastase-induced experimental aneurysms in rats.

Authors:  S Anidjar; J L Salzmann; D Gentric; P Lagneau; J P Camilleri; J B Michel
Journal:  Circulation       Date:  1990-09       Impact factor: 29.690

6.  Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms.

Authors:  E L Henderson; Y J Geng; G K Sukhova; A D Whittemore; J Knox; P Libby
Journal:  Circulation       Date:  1999 Jan 5-12       Impact factor: 29.690

7.  Prevention of aneurysm development and rupture by local overexpression of plasminogen activator inhibitor-1.

Authors:  E Allaire; D Hasenstab; R D Kenagy; B Starcher; M M Clowes; A W Clowes
Journal:  Circulation       Date:  1998-07-21       Impact factor: 29.690

8.  Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. The UK Small Aneurysm Trial Participants.

Authors: 
Journal:  Lancet       Date:  1998-11-21       Impact factor: 79.321

9.  Cell-free arterial grafts: morphologic characteristics of aortic isografts, allografts, and xenografts in rats.

Authors:  E Allaire; C Guettier; P Bruneval; D Plissonnier; J B Michel
Journal:  J Vasc Surg       Date:  1994-03       Impact factor: 4.268

10.  Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall.

Authors:  K M Newman; J Jean-Claude; H Li; J V Scholes; Y Ogata; H Nagase; M D Tilson
Journal:  J Vasc Surg       Date:  1994-11       Impact factor: 4.268

View more
  17 in total

Review 1.  Smooth muscle cells and the formation, degeneration, and rupture of saccular intracranial aneurysm wall--a review of current pathophysiological knowledge.

Authors:  Juhana Frösen
Journal:  Transl Stroke Res       Date:  2014-04-01       Impact factor: 6.829

2.  Autologous adipose-derived mesenchymal stem cells improve healing of coiled experimental saccular aneurysms: an angiographic and histopathological study.

Authors:  Aymeric Rouchaud; Waleed Brinjikji; Daying Dai; Yong-Hong Ding; Tina Gunderson; Dana Schroeder; Laurent Spelle; David F Kallmes; Ramanathan Kadirvel
Journal:  J Neurointerv Surg       Date:  2017-01-11       Impact factor: 5.836

3.  Upregulation of protein kinase cdelta in vascular smooth muscle cells promotes inflammation in abdominal aortic aneurysm.

Authors:  Sebastian Schubl; Shirling Tsai; Evan J Ryer; Chunjie Wang; June Hu; K Craig Kent; Bo Liu
Journal:  J Surg Res       Date:  2008-05-13       Impact factor: 2.192

4.  Perspectives on stem cell-based elastic matrix regenerative therapies for abdominal aortic aneurysms.

Authors:  Chris A Bashur; Raj R Rao; Anand Ramamurthi
Journal:  Stem Cells Transl Med       Date:  2013-05-15       Impact factor: 6.940

Review 5.  Digging in the "soil" of the aorta to understand the growth of abdominal aortic aneurysms.

Authors:  John A Curci
Journal:  Vascular       Date:  2009 May-Jun       Impact factor: 1.285

6.  Utility of hyaluronan oligomers and transforming growth factor-beta1 factors for elastic matrix regeneration by aneurysmal rat aortic smooth muscle cells.

Authors:  Chandrasekhar R Kothapalli; Carmen E Gacchina; Anand Ramamurthi
Journal:  Tissue Eng Part A       Date:  2009-11       Impact factor: 3.845

Review 7.  Turning back the clock: regression of abdominal aortic aneurysms via pharmacotherapy.

Authors:  Hiroki Aoki; Koichi Yoshimura; Masunori Matsuzaki
Journal:  J Mol Med (Berl)       Date:  2007-05-24       Impact factor: 4.599

8.  Autologous mesenchymal stem cell endografting in experimental cerebrovascular aneurysms.

Authors:  Aymeric Rouchaud; Clément Journé; Liliane Louedec; Véronique Ollivier; Mohammed Derkaoui; Jean-Baptiste Michel; Mikael Mazighi
Journal:  Neuroradiology       Date:  2013-03-21       Impact factor: 2.804

9.  Long term stabilization of expanding aortic aneurysms by a short course of cyclosporine A through transforming growth factor-beta induction.

Authors:  Jianping Dai; Stéphanie Michineau; Grégory Franck; Pascal Desgranges; Jean-Pierre Becquemin; Marianne Gervais; Eric Allaire
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

10.  A novel method for differentiation of human mesenchymal stem cells into smooth muscle-like cells on clinically deliverable thermally induced phase separation microspheres.

Authors:  Nina Parmar; Raheleh Ahmadi; Richard M Day
Journal:  Tissue Eng Part C Methods       Date:  2014-10-14       Impact factor: 3.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.